LCT

Living Cell Technologies (LCT)

Stock Code

LCT

Stock Exchange

ax

Living Cell Technologies (LCT) injects healthy cells to replace or repair damaged organs without the use of toxic drugs. The company targets Huntington's disease, stroke, type 1 diabetes and haemophilia. LCT's product portfolio consists of NeurotrophinCell (potential treatment of diseases of nervous system such as Huntington's disease and stroke), Fac8Cell (producing factor 8, blood clotting agent absent or defective in people suffering haemophilia) and DiabeCell (treatment of insulin-dependent diabetes).

Living Cell Technologies Dividends

18 October, 2010 - 01:11

Examine the list of historical dividends for Living Cell Technologies. Dividends are payments made by a corporation to its shareholder members. It is the portion of corporate profits paid out to stockholders. If Living Cell Technologies Limited has declared a dividend, you may be eligible to receive LCT dividends if the share trader the company's stock on the ex-dividend date. Investors must have purchase the shares before the ex dividend date to be entitled to the dividend declared by the company.

Syndicate content

Recommended Websites